Merus logo 300dpi_.jpg
Merus Announces Abstract Accepted for Presentation at the ESMO Asia Congress 2024
September 17, 2024 09:00 ET | Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative,...
Electra_BM_logo_colors.jpg
Electra to Discuss Partnership Opportunities at Indonesian Critical Minerals Summit
August 30, 2024 07:30 ET | Electra Battery Materials Corporation
TORONTO, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) is pleased to announce its participation in Indonesia’s...
Access_Logo_RGB_Full_Color2020.jpg
Triyam Recognized on Inc. 5000 List for the Fourth Consecutive Year
August 15, 2024 09:00 ET | Access Information Management Shared Services, LLC
Company ranking leveled up 999 spots on this highlighted list of America’s Fastest-Growing Private Companies
Merus logo.jpg
Merus to Present at Canaccord Genuity’s 44th Annual Growth Conference
August 06, 2024 08:00 ET | Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific...
Merus logo.jpg
Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
August 01, 2024 16:10 ET | Merus N.V.
– Petosemtamab in combination with pembrolizumab interim data presented at 2024 ASCO® demonstrated robust 67% response rate among 24 evaluable patients – First patients dosed in phase 3 trial...
Merus logo.jpg
Merus Announces First Patient Dosed in LiGeR-HN2, a Phase 3 Trial Evaluating Petosemtamab in 2/3L r/m HNSCC
July 24, 2024 07:00 ET | Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 24, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative,...
Annual Foreign Inves
Annual Foreign Investment in U.S. Existing Homes Sales Decreased 21.2% to $42 Billion
July 17, 2024 09:00 ET | National Association of Realtors®
Washington, D.C., July 17, 2024 (GLOBE NEWSWIRE) -- Key Highlights International buyers purchased $42 billion worth of U.S. residential properties from April 2023 to March 2024, down 21.2%...
VistaJet_Beefbar
VistaJet flights are the newest global location to experience Beefbar’s award winning cuisine
July 10, 2024 04:00 ET | VistaJet International Ltd
Beefbar crafted an exclusive menu for VistaJet Members departing from Paris, Milan, and Nice Monaco, July 10, 2024: VistaJet, the first and only global business aviation company,...
Merus logo.jpg
Merus Announces First Patient Dosed in Phase 2 Trial of Petosemtamab in 2L CRC
July 08, 2024 08:00 ET | Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative,...
Merus logo.jpg
Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer
July 01, 2024 08:00 ET | Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative,...